Published in Am J Pathol on March 01, 1991
Tissue architecture: the ultimate regulator of epithelial function? Philos Trans R Soc Lond B Biol Sci (1998) 1.40
Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer (1993) 1.36
Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor. J Clin Invest (1992) 1.30
Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malign tumour transformation. Gut (1992) 1.19
Collagen receptor control of epithelial morphogenesis and cell cycle progression. Am J Pathol (1999) 1.16
Altered integrin expression in adenocarcinoma of the breast. Analysis by in situ hybridization. Am J Pathol (1993) 1.15
Cell surface molecules and their prognostic values in assessing colorectal carcinomas. Ann Surg (2000) 1.08
Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol (1993) 1.05
Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance. World J Gastroenterol (2002) 1.02
Meeting the biologic challenge of colorectal metastases. Clin Exp Metastasis (2012) 0.97
Expression of alpha(v)beta6 integrin in oral leukoplakia. Br J Cancer (2000) 0.96
Expression of the VLA beta 1 integrin family in bladder cancer. Am J Pathol (1994) 0.96
Altered glycosylation of integrin adhesion molecules in colorectal cancer cells and decreased adhesion to the extracellular matrix. Gut (1993) 0.95
Multiplicity of fibronectin-binding alpha V integrin receptors in colorectal cancer. Br J Cancer (1996) 0.91
Distribution of integrin cell adhesion molecules in endometrial cancer. Am J Pathol (1995) 0.88
Distribution of VLA integrins in solid tumors. Emergence of tumor-type-related expression. Patterns in carcinomas and sarcomas. Am J Pathol (1993) 0.88
Expression of the integrin alpha5 subunit and its mediated cell adhesion in hepatocellular carcinoma. J Cancer Res Clin Oncol (1997) 0.87
The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition. Front Immunol (2014) 0.86
BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells. J Biol Chem (2011) 0.86
Integrins: a role as cell signalling molecules. Mol Pathol (1999) 0.85
Extracellular matrix components induce endocrine differentiation in vitro in NCI-H716 cells. Am J Pathol (1993) 0.84
Integrin expression in esophageal squamous cell carcinoma: loss of the physiological integrin expression pattern correlates with disease progression. PLoS One (2014) 0.83
P-selectin activates integrin-mediated colon carcinoma cell adhesion to fibronectin. Exp Cell Res (2006) 0.83
Invasive potentials of gastric carcinoma cell lines: role of alpha 2 and alpha 6 integrins in invasion. J Cancer Res Clin Oncol (1997) 0.83
Predominant role of alpha 4-integrins for distinct steps of lymphoma metastasis. Proc Natl Acad Sci U S A (1996) 0.81
Prognostic value of β1 integrin expression in colorectal liver metastases. Int J Clin Exp Pathol (2013) 0.80
α2 Integrin-Dependent Suppression of Pancreatic Adenocarcinoma Cell Invasion Involves Ectodomain Regulation of Kallikrein-Related Peptidase-5. J Oncol (2011) 0.80
Impairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3. Genes Cancer (2014) 0.79
Regulation of keratin and integrin gene expression in cancer and drug resistance. Cytotechnology (1998) 0.77
Application of a novel method of double APAAP staining with subsequent quantitative image analysis to the examination of integrin expression in undifferentiated-type gastric carcinomas. J Histochem Cytochem (2009) 0.75
Focal Adhesion Kinase-Dependent Role of the Soluble Form of Neurotensin Receptor-3/Sortilin in Colorectal Cancer Cell Dissociation. Int J Mol Sci (2016) 0.75
Imaging of dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living rats. Eur J Nucl Med Mol Imaging (2003) 0.75
Integrins: a family of cell surface receptors. Cell (1987) 21.14
New perspectives in cell adhesion: RGD and integrins. Science (1987) 18.41
The spread of rectal cancer and its effect on prognosis. Br J Cancer (1958) 10.06
Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell (1985) 8.55
Fibronectin and its receptors. Annu Rev Biochem (1988) 7.06
Laminin receptor on platelets is the integrin VLA-6. Nature (1988) 4.91
Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J Cell Biol (1987) 4.85
The VLA protein family. Characterization of five distinct cell surface heterodimers each with a common 130,000 molecular weight beta subunit. J Biol Chem (1987) 4.47
Laminin and other basement membrane components. Annu Rev Cell Biol (1987) 3.73
Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor alpha 4 beta 1. Cell (1990) 3.46
A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells. Cell (1989) 3.34
The alpha 1/beta 1 and alpha 6/beta 1 integrin heterodimers mediate cell attachment to distinct sites on laminin. J Cell Biol (1990) 3.07
Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem (1986) 3.06
Characterization of the cell surface heterodimer VLA-4 and related peptides. J Biol Chem (1987) 2.94
A complex of platelet glycoproteins Ic and IIa identified by a rat monoclonal antibody. J Biol Chem (1987) 2.94
A novel integrin (alpha E beta 4) from human epithelial cells suggests a fourth family of integrin adhesion receptors. EMBO J (1989) 2.87
Adhesive protein receptors on hematopoietic cells. Immunol Today (1988) 2.85
Fibronectin receptor structures in the VLA family of heterodimers. Nature (1987) 2.54
The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg++-dependent adhesion of platelets to collagen. J Cell Biol (1989) 2.44
Association of the VLA alpha 6 subunit with a novel protein. A possible alternative to the common VLA beta 1 subunit on certain cell lines. J Biol Chem (1989) 2.34
The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others. Proc Natl Acad Sci U S A (1989) 2.31
Endothelial cells use alpha 2 beta 1 integrin as a laminin receptor. J Cell Biol (1989) 2.31
Multiple very late antigen (VLA) heterodimers on platelets. Evidence for distinct VLA-2, VLA-5 (fibronectin receptor), and VLA-6 structures. J Biol Chem (1988) 2.20
Affinity chromatographic isolation of the melanoma adhesion receptor for the IIICS region of fibronectin and its identification as the integrin alpha 4 beta 1. J Biol Chem (1990) 2.08
Peyer's patch-specific lymphocyte homing receptors consist of a VLA-4-like alpha chain associated with either of two integrin beta chains, one of which is novel. EMBO J (1989) 2.04
Renewal of the epithelium in the descending colon of the mouse. I. Presence of three cell populations: vacuolated-columnar, mucous and argentaffin. Am J Anat (1971) 1.98
Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2. J Immunol (1987) 1.90
Interactions of a neuronal cell line (PC12) with laminin, collagen IV, and fibronectin: identification of integrin-related glycoproteins involved in attachment and process outgrowth. J Cell Biol (1987) 1.78
Purification and characterization of mammalian integrins expressed by a rat neuronal cell line (PC12): evidence that they function as alpha/beta heterodimeric receptors for laminin and type IV collagen. J Cell Biol (1988) 1.76
Gastrointestinal epithelial renewal. Gastroenterology (1977) 1.74
Integrin VLA-3: ultrastructural localization at cell-cell contact sites of human cell cultures. J Cell Biol (1989) 1.72
Isolation and characterization of a platelet surface collagen binding complex related to VLA-2. Biochem Biophys Res Commun (1988) 1.57
Molecular cloning of the rat integrin alpha 1-subunit: a receptor for laminin and collagen. J Cell Biol (1990) 1.54
VLA-1: a T cell surface antigen which defines a novel late stage of human T cell activation. Eur J Immunol (1985) 1.53
Widespread histologic distribution of the alpha 2 beta 1 integrin cell-surface collagen receptor. Am J Pathol (1990) 1.48
Very late activation antigens on rheumatoid synovial fluid T lymphocytes. Association with stages of T cell activation. J Clin Invest (1986) 1.43
Alterations in integrin receptor expression on chemically transformed human cells: specific enhancement of laminin and collagen receptor complexes. J Cell Biol (1990) 1.34
Platelet glycoproteins Ia, Ic, and IIa are physicochemically indistinguishable from the very late activation antigens adhesion-related proteins of lymphocytes and other cell types. J Clin Invest (1988) 1.31
Mechanism of fibronectin-mediated cell migration: dependence or independence of cell migration susceptibility on RGDS-directed receptor (integrin). Exp Cell Res (1989) 1.28
Human melanoma cells express a novel integrin receptor for laminin. J Biol Chem (1989) 1.16
Glycoprotein Ic-IIa functions as an activation-independent fibronectin receptor on human platelets. J Cell Biol (1988) 1.13
The human cell surface glycoprotein complex (gp 120,200) recognized by monoclonal antibody K20 is a component binding to phytohaemagglutinin on T cells. Scand J Immunol (1986) 1.10
The fine structure of human rectal mycosa. The epithelial lining of the base of the crypt. Gastroenterology (1968) 1.08
CELL REPLICATION IN THE GASTROINTESTINAL TRACT OF MAN. Gastroenterology (1965) 1.06
Expression of the VLA family of integrins in human intestine. J Pathol (1990) 1.01
Identification of integrin-like matrix receptors with affinity for interstitial collagens. J Biol Chem (1989) 0.98
The in vitro invasiveness and interactions with laminin of K-1735 melanoma cells. Evidence for different laminin-binding affinities in high and low metastatic variants. Clin Exp Metastasis (1989) 0.88
Leukocyte adhesion molecules involved in inflammation. Transplant Proc (1989) 0.86
Reduced cell adhesion to fibronectin and laminin is associated with altered glycosylation of beta 1 integrins in a weakly metastatic glycosylation mutant. Int J Cancer (1989) 0.85
The laminin receptor and basement membrane dissolution: role in tumour metastasis. Ciba Found Symp (1984) 0.83
Anti-(Arg-Gly-Asp-Ser) antibody and its interaction with fibronectin, fibrinogen and platelets. Eur J Biochem (1988) 0.79
K20 and ICO-10 monoclonal antibodies (gp120/200; Thy-1): immunophenotyping of human solid tumours. Br J Cancer (1990) 0.78
Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (1989) 7.76
Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest (1993) 3.13
Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord (2001) 2.94
Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci U S A (1995) 2.60
Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res (1987) 2.22
T cell awareness of paternal alloantigens during pregnancy. Science (1995) 2.12
Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial. Eur Respir J (2011) 2.09
Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res (2000) 2.09
Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy (1999) 2.02
Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol (1992) 1.94
Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood (1996) 1.85
Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-gamma. J Immunol (1986) 1.82
CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology (1997) 1.81
Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest (1993) 1.80
Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci U S A (1996) 1.80
Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene (2006) 1.79
Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J Biol Chem (1990) 1.77
Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol (1989) 1.65
Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer (2001) 1.61
Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res (1990) 1.61
Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol (1978) 1.58
T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopes. J Immunol (1985) 1.58
An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells. J Exp Med (1980) 1.50
Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer (2001) 1.49
Outcome after emergency surgery for cancer of the large intestine. Br J Surg (1991) 1.48
Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer. Int J Cancer (1986) 1.48
T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas. J Immunol (1998) 1.44
Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol (2001) 1.42
Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol (1992) 1.40
The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg (1987) 1.40
Genomic imbalances are rare in hairy cell leukemia. Genes Chromosomes Cancer (1999) 1.39
Estimation of surface area and length with the orientator. J Microsc (1990) 1.38
Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. J Immunol (2001) 1.38
The stem cell-associated Hiwi gene in human adenocarcinoma of the pancreas: expression and risk of tumour-related death. Br J Cancer (2008) 1.36
Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group. Lancet (1999) 1.35
Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. J Immunol (1999) 1.34
Human colorectal cancer: high frequency of deletions at chromosome 1p35. Cancer Res (1990) 1.33
Heterogeneity of the first cluster of differentiation: characterization and epitopic mapping of three CD1 molecules on normal human thymus cells. J Immunol (1986) 1.32
Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br J Cancer (1987) 1.30
Sex-specific telomere length profiles and age-dependent erosion dynamics of individual chromosome arms in humans. Cytogenet Genome Res (2006) 1.24
Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum Gene Ther (1996) 1.23
Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74). J Immunol (1991) 1.23
Are nitrite and N-nitroso compounds in gastric juice risk factors for carcinoma in the operated stomach? Lancet (1980) 1.21
Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res (1998) 1.21
T cell activation via CD2 [T, gp50]: the role of accessory cells in activating resting T cells via CD2. J Immunol (1986) 1.19
Rapid onset of apoptosis in vitro follows disruption of beta 1-integrin/matrix interactions in human colonic crypt cells. Gastroenterology (1996) 1.17
In vivo induction of H-2K/D antigens by recombinant interferon-gamma. Eur J Immunol (1986) 1.15
Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy. Int J Cancer (1987) 1.13
Lipoid pneumonia: an occupational hazard of fire eaters. Br Med J (Clin Res Ed) (1985) 1.13
Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma. J Immunol (1989) 1.13
Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation. Blood (1987) 1.12
In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis. Gut (1995) 1.12
A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity. J Exp Med (1993) 1.11
Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res (1991) 1.11
Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature. Ann Oncol (1995) 1.10
The human cell surface glycoprotein complex (gp 120,200) recognized by monoclonal antibody K20 is a component binding to phytohaemagglutinin on T cells. Scand J Immunol (1986) 1.10
Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol (1998) 1.09
Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J Surg Oncol (1990) 1.08
Recurrence of colorectal tumors: PET evaluation. Radiology (1989) 1.07
Human T cell differentiation antigens and correlation of their expression with various markers of T cell maturation. J Immunol (1979) 1.06
Absence of the JAK2 V617F activating mutation in classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma. Leukemia (2006) 1.06
Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol (1997) 1.05
Quality of life and functional results following different types of resection for gastric carcinoma. Eur J Surg Oncol (1990) 1.05
Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules. J Leukoc Biol (1998) 1.05
Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines. Cancer Res (2000) 1.05
ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients. Oncogene (2010) 1.05
Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. Leukemia (2006) 1.04
CD100 is associated with CD45 at the surface of human T lymphocytes. Role in T cell homotypic adhesion. J Immunol (1996) 1.04
Enhancement of T-lymphocyte differentiation in vitro by thymic extracts after bone marrow transplantation in severe combined immunodeficiencies. Clin Immunol Immunopathol (1975) 1.04
Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma. Cancer Res (1991) 1.03
Subsets of malignant lymphomas in children related to the cell phenotype. Blood (1979) 1.03
Clustering of colonic lamina propria CD4(+) T cells to subepithelial dendritic cell aggregates precedes the development of colitis in a murine adoptive transfer model. Lab Invest (2001) 1.03
Expression of the common acute lymphoblastic leukemia antigen (CD10) in mesenchymal tumors. Am J Pathol (1989) 1.03
Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer. Oncogene (1995) 1.02
Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma. Blood (1998) 1.02
Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells. J Immunol (2001) 1.02
Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens. Immunology (1995) 1.02
High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. Blood (1996) 1.01
Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro. J Virol (1994) 1.01
Lectin target cells in human central nervous system and the pituitary gland. Histochemistry (1984) 1.01
Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg). Clin Exp Immunol (1993) 1.01
Differential effects of caspase-1/interleukin-1beta-converting enzyme on acinar cell necrosis and apoptosis in severe acute experimental pancreatitis. Lab Invest (2001) 1.00
Activation signals are delivered through two distinct epitopes of CD100, a unique 150 kDa human lymphocyte surface structure previously defined by BB18 mAb. Int Immunol (1995) 1.00
Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood (1999) 1.00
LiSa-2, a novel human liposarcoma cell line with a high capacity for terminal adipose differentiation. Int J Cancer (2000) 1.00
Separation of amino acid enantiomers and chiral amines using precolumn derivatization with (+)-1-(9-fluorenyl)ethyl chloroformate and reversed-phase liquid chromatography. Anal Chem (1987) 1.00
Langerhans' cell histiocytosis. Definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples. Am J Surg Pathol (1995) 1.00
Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas. Br J Cancer (1992) 0.99
Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL-10 production. Eur J Immunol (2000) 0.99
B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain. Int J Cancer (1987) 0.99
Synthesis of positively charged phthalocyanines and their activity in the photodynamic therapy of cancer cells. Photochem Photobiol (1990) 0.99
Setting up a decision support system with decision tables. Methods Inf Med (1989) 0.99
Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization. Genes Chromosomes Cancer (1999) 0.99
Antigenic profile of mammary fibroadenoma and cystosarcoma phyllodes. A study using antibodies to estrogen- and progesterone receptors and to a panel of cell surface molecules. Pathol Res Pract (1990) 0.98
Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol (1999) 0.98